[Angiotensin II antagonist for heart insufficiency].
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D000803:Angiotensin I / Q000187:drug effects; D000804:Angiotensin II / Q000187:drug effects*; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use*; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use*; D001713:Biphenyl Compounds / Q000627:therapeutic use*; D006333:Heart Failure / Q000188:drug therapy* / Q000401:mortality; D006801:Humans; D007093:Imidazoles / Q000627:therapeutic use*; D019808:Losartan; D011379:Prognosis; D013777:Tetrazoles / Q000627:therapeutic use*
D000319:Adrenergic beta-Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D000889:Anti-Arrhythmia Agents; D001713:Biphenyl Compounds; D007093:Imidazoles; D013777:Tetrazoles; D000804:Angiotensin II; D000803:Angiotensin I; D019808:Losartan
Angiotensin II-Antagonismus kontra Herzinsuffizienz.